Skip to main content

Table 3 The result of meta-regression

From: A meta-analysis on the risk factors adjusted association between cardiovascular disease and COVID-19 severity

Variables

HR

OR

Tau²

t-value

P-value

Tau²

t-value

P-value

Sample size

0.0753

-0.3248

0.0007

0.0931

-0.1552

0.0449

>=1000

      

<1000

      

Age

0.0552

-

0.1123

0.0746

-

0.3495

>=60

 

0.1404

0.1206

 

0.1006

0.1674

<60

      

NR

 

0.7562

0.1143

 

0.1713

0.5027

Male (%)

0.0734

0.0351

0.7253

0.0997

-

0.0086

>=50

    

-0.0678

0.4355

<50

      

NR

    

0.4272

0.0119

Study design

0.0774

-

0.0828

0.0796

-

0.8863

Retrospective/case series

 

0.1064

0.3152

 

-0.0034

0.9647

Prospective study

 

0.1064

0.1628

 

-0.0823

0.6301

Others

      

Region

0.0651

-

0.1800

0.0601

-

<0.0001

Europe

 

-0.1169

0.2910

 

-0.0307

0.7439

North America

 

-0.2287

0.0746

 

-0.2362

0.0132

Asia

      

Others

 

0.3260

0.3447

 

1.3471

<0.0001

Disease

0.0702

-

0.8655

0.1005

-

0.4005

CVD

 

-0.1123

0.4286

 

0.1737

0.1365

Cardiac disease

 

-0.0681

0.6418

 

0.1620

0.1741

HF

 

-0.1221

0.5212

 

0.2230

0.0640

CAD

      

Others

    

0.82

0.413

Outcomes

0.0694

-

0.0375

0.0810

-

0.1400

Mortality

 

-0.0990

0.6880

 

-0.1298

0.2733

Severity

 

-0.4713

0.0915

 

-0.2786

0.0528

Disease progression

     Â